Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026
Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm
Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch [Yahoo! Finance]
Tandem Diabetes Care (TNDM) was upgraded by Truist Financial Corporation from "hold" to "buy". They now have a $35.00 price target on the stock, up from $27.00.
Tandem Diabetes Care (TNDM) was upgraded by Piper Sandler from "neutral" to "overweight". They now have a $33.00 price target on the stock.